Figure 1
From: PRAS40 promotes NF-κB transcriptional activity through association with p65
PRAS40 overexpression predicts adverse survival time of lung adenocarcinoma and cutaneous melanoma. (a, b) The distribution of PRAS40 mRNA expression in lung adenocarcinoma (a) and cutaneous melanoma (b), x axis, RSEM of PRAS40 mRNA; y axis, the relative frequency corresponding to RSEM in x axis. (c, d) Kaplan–Meier plots for survival analysis were created and compared between the PRAS40-High and PRAS40-Normal groups in lung adenocarcinoma (c) and cutaneous melanoma (d).
